Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / @xirurgi_2025 / @xirurgi_2025 - 386 - файл

.pdf
Скачиваний:
0
Добавлен:
29.08.2026
Размер:
47 Мб
Скачать
216
https://t.me/medicina_free
J. H. Bortz and H. Friedrich-Nel
the tumour and minimise the exposure of chemo­therapy to the normal surrounding tissue.
Chemotherapy may cause side effects such as vomiting, nausea, diarrhoea, neuropathy, or mouth sores. A patient may also feel tired, with an increased risk of infection. Other side effects include neuropathy, tingling, or numbness in feet or hands. Side effects are drug dependent and can be treated with prescribed medication [34].
15.8 Radiation Therapy
External-beam radiation therapy is commonly used for patients with CRC and can take various forms [34]. Endocavitary therapy is applied via the anus and is sometimes used in combination with external-beam radiation therapy. Brachytherapy uses small sources of radioactive material inserted in a tube and placed in or next to the tumour. The advantage of brachytherapy is the high dose to the tumour while the radiation dose to the normal surrounding healthy tissues is minimised. A last radiation therapy treatment option is radioembolisation which is radiation therapy during an embolisation procedure. Preoperative pelvic radiotherapy, with a biologi­cally effective dose of 30Gy or higher, in combi­nation with surgery has shown to improve the local control of the tumour. A short course of pre­operative radiotherapy (e.g., 25Gy in 5 fractions) can reduce the risk of local recurrence.
Side effects from radiation therapy depend on the size of the area being treated as well as the dose. The effects may include fatigue, mild skin reactions, an upset stomach, and loose bowel movements. Bloody stools from bleeding through the rectum or a blockage of the bowel may also be present. Most of the side effects will disappear as soon as the radiation therapy stops [34].
cancer has not grown beyond the inner lining of the bowel. The cancer is local and does not involve surrounding or nearby lymph tissue. Surgery includes any of the following: polypec­tomy, local excision through colonoscope, or colectomy.
• For stage I tumours, surgery remains the main treatment option. No other treatment is required if the polyp or tumour is completely removed as indicated by the histopathology report.
• Stage II cancers have grown through the walls of the bowel and may extend into the sur­rounding tissue but may not be present in the nearby lymph nodes. Recommended therapy includes surgery with adjuvant chemotherapy, specically for those tumours with a moderate to high risk of local recurrence. Radiation therapy may also be an option if there is a risk of local recurrence.
• Stage III cancer has spread to the nearby lymph nodes but not yet to distant sites such as the liver and the lungs. Surgery is done to remove the tumour, a section of the colon/rec­tum as well as the surrounding lymph nodes. Surgery is then followed by adjuvant chemo­therapy. In some cases, the patient may receive chemotherapy before the surgery. If there is a suspicion of local recurrence, radiation ther­apy may also be used. Radiation therapy and/ or chemotherapy remain a favourable treat­ment option for a patient who is not strong enough for surgery.
• Stage IV CRC disease has spread to distant organs and tissue such as the liver, perito­neum, lungs, and distant lymph nodes. These patients will receive chemotherapy and/or tar­geted therapy to control the cancer. Radiation therapy may be used to help relieve symptoms such as pain.
15.8.1 Treatment ofCRC by Stage
There are four stages of CRC [34]. Each stage is briey described. A stage 0 cancer means that the
Local or distant recurrence of the tumour is
treated with surgery, chemotherapy, and /or radiation therapy as it depends on the site and extent of the recurrence.
15 The Adenoma-Carcinoma Sequence, Management, andTreatment ofColon Cancer
https://t.me/medicina_free
217
15.9 Dual-Energy Computed Tomography
The principle of dual-energy computed tomogra­phy (DECT) is based on the photo-electric effect (low energy photon interactions) and Compton effect (high energy photon interactions). These phenomena facilitate the analysis of soft tissue, calcium, and iodine [35]. Single or dual detectors and single or double X-ray tube sources assist to obtain data at two different energy levels, often between 80 and 120kVp [35]. This results in qual­itative and quantitative data of the tissue composi­tion which facilitates the grouping of different pathologies based on photon absorption and Compton scattering at different energy levels [35]. The principles of DECT are discussed in Chap. 26.
The advantage of DECT is tissue differentia­tion, identication, and quantication. For exam­ple, iodine, calcium, or barium can be separated from other tissues using one acquisition scan [36]. Tissue identication and quantication refer to assessment and the presence and amount of, for example, iodine in a specic anatomical region. The measurement of iodine content in tis­sue, for example, helps to differentiate between benign and aggressive CRCs [37]. As such DECT can also distinguish between stool and a polyp without compromising the sensitivity and speci­city of the examination [35, 38]. Additionally, the iodine density measurements can also assist in assessing treatment responses such as deter­mining the size of the tumour in response to treat­ment. These features make DECT useful in oncology imaging without an increase in the radiation dose to the patient [36] (see Chap. 26). Although CTC is regarded as a reliable screening tool [39] and as a gold standard procedure because of the high sensitivity, DECT has the advantage that bowel preparation and/or bowel distention of the patient is not required [35]. This option is therefore pleasant for a patient and pro­vides a positive patient experience [36].
Although DECT is unable to distinguish between an adenoma and carcinoma, it is how­ever useful for preoperative screening for CRCs.
Successful differentiation between metastatic and non-metastatic lymph nodes of rectal cancer was also reported [40, 41]. This is due to the lower iodine concentration in metastatic lymph nodes. DECT is useful for CRC grading [42].
15.10 Articial Intelligence for Diagnosis andStaging ofCRC
A limitation of CTC is that a reader is not able to differentiate benign and malignant lesions. Over the past few years, the role of articial intelli­gence (AI) in medicine has been underscored. For example, according to Yu and Helwig [43] AI has a role for epidemiology of CRC as well as an imaging tool for diagnosis of CRC. Literature reports on the role of AI (machine learning/deep learning) for polyp detection and differentiation in imaging [44, 45]. In addition, literature describes the use of AI in the diagnosis, staging, and treatment of CRC [46, 47]. Kacew etal. [48] are of the opinion that AI can contribute to cut­ting costs in CRC genotyping. A detailed discus­sion of AI and machine learning in imaging is presented in Chap. 25.
15.11 AI Applications inRadiation Therapy
Developments in the use of AI in radiation ther­apy were published recently in a review paper [49]. Santoro etal. [49] retrieved 71 papers of AI applications in radiation therapy planning. These included three papers on iterative optimi­sation (IO), 25 papers on machine learning (ML), and 43 papers on deep learning (DL). The ML technique is used to identify patient specic dose- volume constraints and custom design radiation therapy options and solutions. As these approaches may be time consuming when done manually, utilising IO procedures and auto- planning techniques can reduce the treatment planning time. The advantage of this approach is that there is a consistent production
218
https://t.me/medicina_free
J. H. Bortz and H. Friedrich-Nel
of quality plans with minimal inter-planning variations [49].
Another application is for patient positioning and monitoring, thus to verify that the patient remains in the simulated treatment position. DL-based methods are used that enable accurate patient positioning. As such AI can be used for dynamic motion management models to improve tumour tracking. Irradiation can be interrupted if there is patient motion, or inadequate target posi­tioning. Such algorithms can track and accom­modate real-time breathing motion to track the tumour position in advance, adding to the accu­racy and custom delivery of the radiation therapy [49]. Santoro et al. [49] concluded that more research is required to explore the use of AI, such as auto-planning techniques and its application in the clinical environment. Also, there is a need to develop and implement reliable and trustworthy AI tools as well as looking into the ethical prin­ciples implementing AI in the radiation therapy environment. The WHO [50] underscores the importance of key ethical principles of AI in health.
Key Messages
• Most sporadic cancers arise from an adeno-
matous polyp.
• It takes between 10 and 15years for an ade-
noma to develop into a carcinoma.
• The adenoma-carcinoma pathway is of a can-
cer that arises from an adenomatous polyp.
• The serrated polyp-carcinoma sequence forms
between 15 and 20% of CRCs.
• The onset of CRC is increasing in younger
people.
• Treatment options for CRC include surgery,
chemotherapy, radiation therapy, and targeted
therapy that is usually offered in
combination.
• The treatment protocol depends on the stage
of the CRC and the performance status of the
patient.
• Chemotherapy and radiation therapy have side
effects. These symptoms can be treated with
prescribed medication.
• DECT may be useful for CRC grading.
• Diagnostic CTC, MRI, and PET/CT play a role in TNM staging of CRC.
• Articial intelligence is playing an important role in the diagnosis, treatment, and prognosis of CRC.
15.12 Summary
Colorectal cancer (CRC) remains a major health problem around the world. Apart from inherited genetic disorders, such as hereditary non­polyposis colorectal cancer, most CRCs arise from a pre-existing polyp which develops over a period of 10–15years into a cancer. Knowledge of CRC pathways is important for reporting of polyps detected during CTC studies. Understanding treatment and management of CRC underscore that concerted efforts should be made to reduce persons developing CRC by cor­rectly identifying and reporting advanced adeno­mas on CTC studies.
Acknowledgement Clinton Bopp is thanked for drawing the target line diagram.
References
1. WHO. Cancer. 2022. [cited 2022 September 10].
https://www.who.int/news- room/fact- sheets/detail/ cancer.
2. WHO Implementation roadmap 2023–2030 for the global action plan for the prevention and control of NCDs 2013–2030. [cited 2022 September 10]. https://
www.who.int/teams/noncommunicable- diseases/ governance/roadmap.
3. American Society of Clinical Oncology. 2022. [cited 2022 September 10]. https://www.cancer.net/
cancer- types/colorectal- cancer/statistics.
4. Rajagopalan A, Antoniou E, Rajagopalan E, Arachchi A, Chouhan H, Nguyen TC, Teoh W.Is colorectal cancer associated with altered bowel habits in young patients? ANZ J Surg. 2021;91:943–6.
5. Kim J, Dobson B, Ng Liet Hing C, Cooper M, Lu CT, Nolan G, Von Papen M. Increasing rate of colorec­tal cancer in younger patients: a review of colo­noscopy ndings in patients under 50 at a tertiary institution. ANZ J Surg. 2020;90:2484–9. https://doi.
org/10.1111/ans.16060.
6. Cavestro GM, Zuppardo RA, Mannucci A. Early­onset of colorectal cancer: trends and challenges.
15 The Adenoma-Carcinoma Sequence, Management, andTreatment ofColon Cancer
https://t.me/medicina_free
219
Lancet Gastroenterol Hepatol. 2019;4(7):F491–2.
https://doi.org/10.1016/S2468- 1253(19)30146- 3.
7. Exarchakou A, Donaldson LJ, Girardi F, Coleman MP.Colorectal cancer incidence among young adults in England: trends by anatomical sub-site and depri­vation. PLoS One. 2019;14(12):e0225547. https://doi.
org/10.1371/journal.pone.022554.
8. Araghi M, Soerjomataram I, Bardot A, Ferlay J, Cabasag CJ, Morrison DS, De P, et al. Changes in colorectal cancer incidence in seven high­income countries: a population-based study. Lancet Gastroenterol Hepatol. 2019;4:511–8.
9. American Cancer Society. Guidelines for colorectal cancer screening. [cited 2022 September 18]. https://
www.cancer.org/cancer/colon- rectal- cancer/detection.
10. Screening for colorectal cancer US Preventive Services Task Force recommendation statement. JAMA. 2021;325(19):1965–1977.
11. Johnson DA.Landmark developments in gastroenter­ology. Medscape. 2015. [cited 2022 September 10].
http://www.medscape.com.
12. Muto T, Bussey HJR, Morson BC. The evolution of cancer of the colon and rectum. Cancer. 1975;36:2251–
70. https://doi.org/10.1002/cncr.2820360944.
13. Kim DH, Pickhardt PJ, Taylor AJ.Characteristics of advanced adenomas detected at CT colonographic screening: implication for appropriate size thresh­olds for polypectomy versus surveillance. AJR. 2007;188(4):940–4.
14. Bortz JH.CT colonography: an approach for a success­ful examination. S Afr J Rad. 2014;18(1):607, 11 pages.
https://doi.org/10.4102/sajr.v18i1.607SAJR2014.
15. Obaro AE, Burling D, Plumb AA. The role of imag­ing screening special feature: review article. Br J Radiol. 2018;91:20180307. [cited 2022 September 10]. https://doi.org/10.1259/bjr.20180307.
16. Fillon M. Proximal serrated polyps increase the future risk of colorectal cancer. CA Cancer J Clin. 2020;70(5):317–8. https://doi.org/10.3322/
caac.21624.
17. Lynch HJ, de la Chapelle A. Genomic medi­cine—hereditary colorectal cancer. N Engl J Med. 2003;348(10):919–32.
18. Robbins DH, Itzkowitz SH. The molecular and genetic basis of colon cancer. Med Clin North Am. 2002;86(6):1467–95.
19. Winawer SJ, Zauber A, Diaz B. Temporal sequence of evolving colorectal cancer from the normal colon (abstr). Gastrointest Endosc. 1987;33:167.
20. Obuch JC, Pigott CM, Ahnen SJ. Sessile serrated polyps, detection, eradication, and prevention of the evil twin. Curr Treat Options Gastroenterol. 2015;13(1):156–70.
21. Pickhardt PJ, Arluk GM. Atlas of gastrointesti­nal imaging: radiologic-endoscopic correlation. Philadelphia: Saunders; 2007. p.24.
22. O’Brian MJ. Hyperplastic and serrated polyps of the colorectum. Gastroenterol Clin North Am. 2007;36:947–68.
23. Lynch syndrome approved by the cancer.net. Editorial Board, 12/2014. [cited 2022 September 10]. http://
www.cancer.net/cancer- types/lynch- syndrome.
24. Sali L, Falchini M, Taddei A, Mascalchi M. Role of preoperative CT colonography in patients with colorectal cancer. World J Gastroenterol. 2014;20(14):3795–803. https://doi.org/10.3748/wjg.
v20.i14.3795.
25. Flor N, Ceretti AP, Luigiano C, Brambillasca P, Savoldi AP, Verrusio C, Ferrari D.Performance of CT colonography in diagnosis of synchronous colonic lesions in patients with occlusive colorectal cancer. AJR. 2020;214(2):348–54. https://doi.org/10.2214/
AJR.19.21810.
26. Hong N, Park SH. CT colonography in the diagno­sis and management of colorectal cancer: empha­sis on pre- and post-surgical evaluation. World J Gastroenterol. 2014;20(8):2014–22. https://doi.
org/10.3748/wjg.v20.i8.2014.
27. Laghi A, Neri E, Regge D.Editorial on the European Society of Gastrointestinal Endoscopy (ESGE) and European Society of Gastrointestinal and Abdominal Radiology (ESGAR) guideline on clinical indica­tions for CT colonography in the colorectal cancer diagnosis. Radiol Med. 2015;120:1021–3. https://doi.
org/10.1007/s11547- 015- 0537- x.
28. Maupoey Ibáñez J, Pàmies Guilabert J, Frasson M, Boscà Robledo A, Giner Segura F, García-Granero XE.Accuracy of CT colonography in the preoperative staging of colon cancer: a prospective study of 217 patients. Color Dis. 2019;21(10):1151–63. https://doi.
org/10.1111/codi.14724.
29. Kijima S, Sasaki T, Nagata K, et al. Preoperative evaluation of colorectal cancer using CT colonog­raphy, MRI, and PET/CT. World J Gastroenterol. 2014;20(45):16964–75.
30. Cunliffe WJ, Hasieton PS, Tweedie DE, Schoeld PF. Incidence of synchronous and metachronous colorectal carcinoma. Br J Surg. 1984;71(12):941–3.
31. Heriot AG, Hicks RJ, Drummond EG, Keck J, Mackay J, Chen F, Kalff V. Does positron emis­sion tomography change management in primary rectal cancer? A prospective assessment. Dis Colon Rectum. 2004;47(4):451–8. https://doi.org/10.1007/
s10350- 003- 0089- 3.
32. Stintzing S.F1000Prime Rep. 2014;6:108. Published online 2014 Nov 4. [cited 2022 September 17]. http://
www.ncbi.nlm.nih.gov/pmc/articles/PMC4229728/. https://doi.org/10.12703/P6- 108.
33. SIGN (Scottish Intercollegiate Guidelines Network)
126. 2011. Diagnosis and management of colorec­tal cancer. A national clinical guideline. [cited 2022 September 17]. http://www.sign.ac.uk/pdf/sign126.pdf.
34. Colorectal cancer: treatment options approved by the cancer.net Editorial Board, 09/2014. [cited 2022 September 17]. http://www.cancer.net/cancer- types/
colorectal- cancer/treatment- options.
35. Virarkar MK, Swarupa S, Vulasala R, Gupta AV, Gopireddy DR, Kumar S, Hernandez M, Lall C,
220
https://t.me/medicina_free
J. H. Bortz and H. Friedrich-Nel
Bhosale P.Virtual non-contrast imaging in the abdo­men and the pelvis: an overview. Semin Ultrasound CT MRI. 2022;43(4):293–310. https://doi.org/10.1053/j.
sult.2022.03.004.
36. Ersahin D, Rasla J, Singh A.Dual energy CT applica­tions in oncological imaging. Semin Ultrasound CT MR. 2022;43(4):344–51. https://doi.org/10.1053/j.
sult.2022.04.004.
37. Sato K, Morohashi H, Tsushima F, Sakamoto Y, Miura T, Fujita H, Umemura K, Suzuki T, Tsuruta S, Kura R, Ono S, Aoki M, Hakamada K.Dual energy CT is useful for the prediction of mesenteric and lateral pel­vic lymph node metastasis in rectal cancer. Mol Clin Oncol. 2019;10(6):625–30. https://doi.org/10.3892/
mco.2019.1834.
38. Özdeniz İ, İdilman İS, Köklü S, Hamaloğlu E, Özmen M, Akata D, Karçaaltıncaba M.Dual-energy CT char­acteristics of colon and rectal cancer allows differen­tiation from stool by dual-source CT.Diagn Interv Radiol. 2017;23(4):251–6. https://doi.org/10.5152/
dir.2017.16225.
39. Ricci ZJ, Kobi M, Flusberg M, Yee J.CT colonog­raphy in review with tips and tricks to improve per­formance. Semin Roentgenol. 2021;56(2):140–51.
https://doi.org/10.1053/j.ro.2020.07.007.
40. Yang Z, Zhang X, Fang M, Li G, Duan X, Mao J, Shen J. Preoperative diagnosis of regional lymph node metastasis of colorectal cancer with quanti­tative parameters from dual-energy CT. AJR Am J Roentgenol. 2019;213(1):W17–25. https://doi.
org/10.2214/AJR.18.20843.
41. Qiu L, Hu J, Weng Z, Liu S, Jiang G, Cai X.A pro­spective study of dual-energy computed tomogra­phy for differentiating metastatic and non-metastatic lymph nodes of colorectal cancer. Quant Imaging Med Surg. 2021;11(8):3448–59. https://doi.org/10.21037/
qims- 20- 3.
42. Gong HX, Zhang KB, Wu LM, Baigorri BF, Yin Y, Geng XC, Xu JR, Zhu J. Dual energy spectral CT imaging for colorectal cancer grading: a preliminary study. PLoS One. 2016;11(2):e0147756. https://doi.
org/10.1371/journal.pone.0147756.
43. Yu C, Helwig EJ. The role of AI technology in pre­diction, diagnosis and treatment of colorectal can­cer. Artif Intell Rev. 2022;55(1):323–43. https://doi.
org/10.1007/s10462- 021- 10034- y.
44. Rasouli P, Dooghaie Moghadam A, Eslami P, Aghajanpoor Pasha M, Asadzadeh Aghdaei H, Mehrvar A, Nezami-Asl A, Iravani S, Sadeghi A, Zali MR.The role of articial intelligence in colon polyps detection. Gastroenterol Hepatol Bed Bench. 2020;13(3):191–9.
45. Grosu S, Wesp P, Graser A, Maurus S, Schulz C, etal. Machine learning–based differentiation of benign and premalignant colorectal polyps detected with CT colo­nography in an asymptomatic screening population: a proof-of-concept study. Radiology. 2021;299:326–35.
https://doi.org/10.1148/radiol.2021202363.
46. Bedrikovetski S, Dudi-Venkata NN, Kroon HM, Seow W, Vather R, Carneiro G, Moore JW, Sammour T.Articial intelligence for pre-operative lymph node staging in colorectal cancer: a systematic review and meta-analysis. BMC Cancer. 2021;21(1):1058.
https://doi.org/10.1186/s12885- 021- 08773- w.
47. Liang F, Wang S, Zhang K, Liu TJ, Li JN.Development of articial intelligence technology in diagnosis, treat­ment, and prognosis of colorectal cancer. World J Gastrointest Oncol. 2022;14(1):124–52. https://doi.
org/10.4251/wjgo.v14.i1.124.
48. Kacew AJ, Strohbehn GW, Saulsberry L, Laiteerapong N, Cipriani NA, Kather JN, Pearson AT. Articial intelligence can cut costs while maintaining accuracy in colorectal cancer geno­typing. Front Oncol. 2021;11:630953. https://doi.
org/10.3389/fonc.2021.630953.
49. Santoro M, Strolin S, Paolani G, Della Gala G, Bartoloni A, Giacometti C, Ammendolia I, Morganti AG, Strigari L.Recent applications of articial intel­ligence in radiotherapy: where we are and beyond. Appl Sci. 2022;12(7):3223. https://doi.org/10.3390/
app12073223.
50. Ethics and governance of articial intelligence for health: WHO guidance, 2021.
Colonic Diverticular Disease
https://t.me/medicina_free
JoelH.Bortz
16
16.1 Introduction
Diverticular disease (DD) is the most common benign colonic abnormality in patients over the age of 50years, who present for initial screening studies. The disease is endemic in Western popu­lations; it is therefore considered to be a normal nding on CTC.It is a common gastrointestinal (GIT) disorder largely due to dietary factors. Hence, 50% of all screening adults will show moderate or severe DD, predominantly in the sig­moid colon, and to a lesser extent in the descend­ing colon and right side of the colon [1]. The incidence of DD increases with age with equal prevalence in men and women [2]. Over the last few decades, the prevalence of DD has increased. Approximately 40% of adults below the age of 40years have the disease. This rises to 50–70% in adults up to age of 70years and reaches 85% in persons 80years or older [1]. Asians are more prone to develop colonic DD on the right side of the colon [3].
The following abbreviations are used in the
chapter.
• 2D: two-dimensional
• 3D: three-dimensional
• CO2: carbon dioxide
• CRC: colorectal cancer
J. H. Bortz (*) LSG Imaging, Los Angeles, CA, USA
• DD: diverticular disease
• DDSS: diverticular disease severity score
• FDA: Food and Drug Administration of the
US
• GIT: gastrointestinal tract
• LLD: left lateral decubitus
• OC: optical colonoscopy
• RLD: right lateral decubitus
• USA: United States of America
16.2 Acute Diverticulitis Is
Contraindicated inaCTC Study
Acute diverticulitis is an absolute contraindica­tion for performance of a CTC study [4] because it means that a perforation of a diverticulum has occurred. It may be extremely small. A perfora­tion causes an inammatory reaction in surround­ing mesentery due to a leak of faecal material. If the perforation is larger, this means that greater amounts of faecal material may leak into the peri­toneal cavity causing abscess formation. This is a serious situation which requires use of antibiot­ics. If there is a large volume of uid in the abscess cavity, percutaneous drainage may be required. Abscess formation may result in loops of small and large bowel sticking together; this may eventually result in a stula between them (colo-enteric) or a stula between colon and colon (colo-colic) and also between colon and bladder (colo-vesical) as well as between uterus and colon (colo-uterine).
© The Author(s), under exclusive license to Springer Nature Switzerland AG 2023 J. H. Bortz et al. (eds.), CT Colonography for Radiographers,
https://doi.org/10.1007/978-3-031-30866-6_16
221
222
https://t.me/medicina_free
J. H. Bortz
16.3 Pathogenesis andCause ofColonic Diverticular Disease
What is pathogenesis? It is the biologic mecha­nisms that lead to a disease state. A diverticulum forms as a result of herniation of the mucus membrane lining through a defect in the muscu­lar portion of the bowel wall. DD pathogenesis is thus acquired by herniation (out- pouching) of mucosa and submucosa through the muscularis propria in an area of weakness where the nutrient arteries extend through the submucosa [5]. Figure 16.1 shows outpouching of multiple diverticula.
The cause of colonic DD is not well under­stood. Several theories have been mooted [2, 6,
7]. Low bre diets that are high in rened carbo-
hydrates and low in dietary bre result in less bulky stools that retain less water [5]. This may alter the GIT transit time and may increase intra­colonic pressure. Other causes include disordered colonic mobility [2], high red meat and low fat consumption, and frequent use of anti­inammatory drugs [7].
16.4 Chronic Diverticular Disease Pathological Features
There are several features of the disease [6].
• Myochosis (muscle thickening) and elastin
deposition
• Thickening of the circular muscle
• Shortening of the taeniae
• Decreased compliance
• Luminal narrowing.
16.5 Severity Score ofDiverticular Disease
Literature does include a GDD severity score (DDSS) from 1 to 4 for CTC studies [8]. The score is based on the maximum wall thickness and minimum lumen diameter. For example, DDSS 1 = maximum wall thickness of <3 mm and minimum lumen diameter of 15 mm and DDSS 4=8mm and <5mm, respectively [8]. However, to determine a DDSS requires intrave­nous administration of 100ml of non-ionic con­trast media followed by a 50 ml saline ush immediately after the standard CTC study in order to obtain images during the portal venous stage [8].
Fig. 16.1 Example of outpouching of diverticula (open white arrows) on supine colon-map view
16.6 CTC inPatients withDiverticular Disease
Patients with DD are usually asymptomatic when presenting for CTC screening for detec­tion of colorectal cancer (CRC). Moderate or advanced severity DD is diagnosed in at least 50% of patients who are 50years or older [9]. The sigmoid colon, followed by the descending colon, and then the ascending colon, are mainly the areas of involvement. According to Pickhardt and Kim [10] in view of its high prev­alence, it is not surprising that the disease rep­resents the leading cause of non-diagnostic segmental evaluation at CTC. Diverticula are
16 Colonic Diverticular Disease
https://t.me/medicina_free
223
not problematic in terms of a reader being able to diagnose the disease on CTC studies (see Fig. 16.2a (i) and (ii)). However, inadequate lumen distension, as discussed in Sect. 16.9, and thickened folds may cause possible pitfalls, as discussed in Sect. 12.2.3. Diverticula may
a(i) a(ii)
become lled with inspissated stool and/or bar­ium. When this happens, the diverticula may then bulge into the colonic lumen causing a pol­ypoidal defect on 3D endoluminal views. Figure16.2b (i)–d (ii) are examples of impacted diverticula.
b(i) b(ii)
Fig. 16.2 (a) (i) 3D view of multiple diverticula lled with barium and air (open black arrows). (ii) 2D axial view of multiple diverticula (red circle). (b) (i) 3D view showing diverticulum (black arrow) and impacted diver-
ticulum (green arrow). Polypoidal defect due to stool (white arrow). (ii) 2D axial view shows stool (white arrow) and impacted diverticulum (green arrow). Yellow arrow shows diverticulum.
224
https://t.me/medicina_free
J. H. Bortz
c(i)b(iii)
d(i)c(ii)
d(ii)
Fig. 16.2
ula lled with barium (open red arrow). (c) (i) 3D view of polypoidal lesion due to polyp (open black arrows) and uncomplicated diverticula (open white arrows). (ii) 2 D axial showing impacted diverticulum (green arrow) and
(iii) 2D coronal view shows multiple divertic-
an air-lled diverticulum (red arrow). (d) (i) 3D endolu­minal view of impacted diverticulum (white arrow) and diverticulum (black arrow). (ii) 2D axial shows impacted diverticula (green arrows) and air-lled diverticulum (red arrow)
16 Colonic Diverticular Disease
https://t.me/medicina_free
225
16.7 Visualisation ofDiverticula on2D and3D CTC Images
Most sigmoid diverticula are associated with thickening of the circular muscle layer and short­ened taeniae (myochosis). This may result in luminal narrowing and an ‘accordion-like appear­ance’ [11]. The thickening of the folds as well as luminal narrowing, due to muscular hypertrophy from DD, can cause a confusing picture on both 2D (two-dimensional) as well as 3D (three­dimensional) visualisation. Thick folds may be interpreted as polyps or even possible masses on
a(i) a(ii)
both 2D and 3D endoluminal views [12]. If in doubt, an additional view in the right lateral decubitus (RLD) position, may resolve the image interpretation issue. The presence of mucosal prolapse may also prevent a correct diagnosis being made. Such a prolapse results in a thick­ened redundant fold which may be impossible to distinguish from a true polyp.
Diverticula are easily diagnosed in both 2D and 3D endoluminal views. On 3D views, the ori­ces are surrounded by a recognisable black ring (Fig. 16.3a (i)). On 2D views, the diverticulum extends beyond the colon wall and is usually
a(iii)
Fig. 16.3 (a) (i) 3D view shows orice of diverticulum as a black ring (open white arrow). (ii) 3D view of a narrow neck diverticulum (open black arrows). (iii) 3D view of a wide neck diverticulum (open black arrows)
Соседние файлы в папке @xirurgi_2025